The countermeasures he put forward include: all the products of Chinese medicine non-legacy projects are included in the national medical insurance essential drugs list; Implement the policy of "high quality and good price" for the products of non-legacy projects of traditional Chinese medicine; Set up major special funds for non-legacy products to support Chinese time-honored Chinese medicine enterprises with non-legacy projects to become stronger and bigger; State administration of traditional chinese medicine established the "Traditional Chinese Medicine Time-honored Brand Inheritance and Development Fund" to support the time-honored brand to carry out the inheritance and development of traditional Chinese medicine classic products and diagnosis and treatment projects; In the new GMP certification of the State Administration of Pharmaceutical Products, the ancient processing technology of non-legacy varieties was recognized according to unique skills and standards; When calculating the cost, the price department should fully consider not only the actual input of intangible products, but also the input of intangible assets.